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Objectives. This study used monophasic action potentials to 
investigate he elects of verapamil and propranoloi n epinephrine- 
induced repolarization abnormalities in congenital long QT syn- 
drome. 
Background. Early afterdepolarizations have been suggested to
play a significant role in QT prolongation and ventricular ar- 
rhythmias in congenital long QT syndrome. Calcium channel 
blocking as well as beta-adrenergic blocking agents are reported 
to be effective in the management of this syndrome. 
Methods. Monophasie action potentials from 2 to 4 sites were 
recorded simultaneously in eight patients with the long QT 
syndrome (22 sites) and in eight control patients (23 sites) and 
were obtained uring constant atrial pacing 1) before pinephrine 
infusion; 2) during epinephrine infusion (0.1 /xg/kg body weight 
min); 3) after verapamil injection (0.1 mg/kg) during epinephrine 
infusion; and 4) after both propranolol (0.1 mg/kg) and verapamil 
injections. 
Results. Early afterdepolarizations were recorded in two of the 
eight patients (2 of 22 sites) during the control state. During 
epinephrine infusion, early afterdepolarizations were recorded in 
six patients (six sites), and ventricular premature complexes were 
induced in three and torsade de pointes in one. Epinephrine 
prolonged 90% monophasic action potential duration from 348 _+ 
48 (mean -+ SD) to 381 -+ 49 ms (22 sites, p < 0.0005) and 
increased the dispersion of action potential duration (difference 
between the longest and shortest action potential duration) from 
36 -+ 20 to 64 -+ 34 ms (p < 0.005). Verapamil eliminated (two 
sites) or reduced (four sites) early afterdepolarizations and 
abolished ventricular premature complexes in two of the three 
patients as well as suppressing torsade de pointes. Verapamil 
shortened the action potential duration to 355 -+ 28 ms (p < 0.01 
vs. epinephrine) and decreased the dispersion to 44 -+ 19 ms (p < 
0.05 vs. epinephrine). Propranolol further eliminated (two sites) 
or reduced (two sites) early afterdepolarizations, abolished veu- 
tricular premature complexes in the remaining one patient and 
further shortened the action potential duration to 337 -+ 32 ms 
(p = 0.09 vs. verapamil). In the control patients, none of the early 
afterdepolarizations, ventricular arrhythmias ormarked prolon- 
gations of action potential duration were induced by epinephrine, 
and neither verapamU nor propranolol changed repolarization 
variables. 
Conclusions. These results indicate that both verapamil and 
propranolol can improve repolarization abnormalities induced by 
epinephrine in congenital long QT syndrome. 
(J Am CoU Cardiol 1995;26:1299-309) 
Early aflerdepolarizations and triggered activity have been 
shown to play a significant role in the genesis of QT prolon- 
gation and ventricular arrhythmias in several experimental 
models of the long QT syndrome (1-7). In addition, some 
clinical studies using monophasic action potentials have dem- 
onstrated irect evidence of early afterdepolarizations in pa- 
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tients with both congenital (8-12) and acquired (13-15) long 
QT syndrome. In congenital long QT syndrome, sympathetic 
stimulation, or catecholamines, are known to produce QT 
prolongation and ventricular arrhythmias, which are often 
linked to syncope or sudden death. Moreover, some recent 
studies (11,12,16,17) using monophasic action potentials have 
shown that catecholamine-enhanced earlyafterdepolarizations 
arc associated with ventricular arrhythmias. Commensurate 
with the influence of catecholamines, beta-adrenergic blocking 
agents are widely reported to reduce the incidence of syncope 
and sudden death (18,19). In addition, calcium channel block- 
ing agents (e.g., verapamil) have recently been reported 
(10,12,17,20) to be effective in the suppression of early after- 
depolarizations and ventricular arrhythmias in some patients 
with the congenital long QT syndrome. The present study 
sought o I) examine the influence of epinephrine (alpha- and 
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Table 1. Clinical Characteristics of Eight Patients With the Long QT Syndrome and Eight Control Patients 
ECG Findings 
Symptoms Sinus Cycle Serum Electrolytes 
Age (yr)/ Syncope Length QTc Notched T Wave T Wave K Mg 
Pt No. Gender Diagnosis With Stress TdP (ms) (ms 1'~) in Three Leads Alternans (mEq/liter) (mg/dl) 
Pts with LOTS 
1 19/F RW 
2 23/F RW 
3 18/F Idp 
4 24/F RW 
5 12/M RW 
6 11/M RW 
7 3/M RW 
8 6/M RW 
Control pts 
1 44/M Con WPW 
2 57/M Con WPW 
3 57/M Con WPW 
4 40/F Con WPW 
5 55/F Con WPW 
6 36/F Con WPW 
7 42/F Con WPW 
8 25/F Con WPW 
+ - 760 670 + - 4.0 2.1 
+ -- 1,180 650 + + 4.1 2,1 
+ - 940 580 - - 4.0 1,9 
+ + 820 620 - - 4.0 2,2 
+ - 1,000 600 + - 4.3 2,0 
+ + 700 570 - - 4.6 1.9 
+ + 740 740 + + 4.1 2,2 
+ + 880 600 - + 4.0 1.9 
770 400 - - 4.2 2.0 
1,000 410 - - 4.3 2.1 
970 420 - - 4.1 2.0 
780 430 - - 4.2 2.2 
960 390 - - 4.0 2.2 
820 410 - - 4.1 1.9 
720 410 - - 4.3 2.1 
840 410 - 4.1 2.0 
Con WPW = concealed Wolff-Parkinson-White syndrome; ECG : electrocardiographic; F = female; ldp = idiopathic; LQTS= congenital long QT syndrome; 
M = male; QTc = corrected QT interval; Pt = patient; RW = Romano-Ward syndrome; TdP = torsade de pointes; + = present; - = absent. 
beta-adrenergic stimulation) on early afterdepolarizations, 
ventricular arrhythmias and action potential duration in pa- 
tients with the congenital long QT syndrome; and 2) investi- 
gate the effects of verapamil and propranolol (beta-blocker) on 
these variables. 
Methods 
Subjects. Congenital long QT syndrome was defined ac- 
cording to the new diagnostic riteria of Schwartz et al. (21): 1) 
a corrected QT (QTc) interval ->450 mslJ2; 2) a history of 
syncope with stress; 3) polymorphic ventricular tachycardia 
characteristic of torsade de pointes; and 4) family members 
with definite congenital long QT syndrome. Eight consecutive 
patients with the congenital long QT syndrome were entered 
into the study between January 1992 and June 1994 (four 
female, four male; mean age [_+SD] 15 = 8 years, range 3 to 
24) (Table 1). One patient (Patient 2) was described in an 
earlier case report (12). The long QT syndrome was familial 
(Romano-Ward syndrome) in seven patients and idiopathic in 
one. All eight patients had a histo~ of stress-induced syncope, 
and torsade de pointes was documented in six. Four patients 
had notched T wave in three leads, and T wave alternans was 
present in three. All eight patients had a mean QTc interval of 
629 - 56 ms ~/2 (range 570 to 740) that was observed sponta- 
neously in response to emotional stress or exercise and was 
unrelated to antiarrhythmic agents, electrolyte abnormalities 
or any other causes leading to QT prolongation. Therefore, all 
eight patients had a score >4 points (range 5 to 8.5 points, 
mean 6.8 _+ 1.1) according to the new diagnostic riteria of 
Schwartz et al. (21), indicating ahigh probability of congenital 
long QT syndrome. Eight control patients with concealed 
Wolff-Parkinson-White syndrome and a normal QT interval 
were also studied after successful radiofrequency atheter 
ablation for accessory atrioventricular connections toevaluate 
the effects of epinephrine, verapamil and propranolol on 
monophasic action potentials (five women, three men; mean 
age 45 + 11 years, range 25 to 57; mean QTc interval 410 _+ 
12 ms 1/2) (Table 1). 
Electrophysiologic studies. All protocols were reviewed 
and approved by our Ethical Review Committee, and written 
informed consent was obtained from all patients or their 
parents. (Because four patients were minors, the purpose of 
the study [that he effects of verapamil and propranolol n the 
action potential were to be examined irectly using the 
monophasie action potential] was explained, and informed 
consent was obtained from the parents.) Electrophysiologic 
studies were performed in the nonsedated, postabsorbed state 
in all but two patients with the long QT syndrome (Patients 7
and 8) who received sodium pentobarbital (3 mg/kg body 
weight) and diazepam (0.3 mg/kg) as sedation. All antiarrhyth- 
mic medications were discontinued for at least five drug 
half-lives. 
Two or three 6F or 7F monophasic action potential cathe- 
ters (monophasic action potential-pacing combination cathe- 
ter, EP Technologies) were introduced through afemoral vein 
and advanced into the right ventricle under fluoroscopic 
guidance to record the right ventricular monophasic action 
potentials. Another 6F or 7F catheter was also introduced 
through afemoral artery and advanced into the left ventricle to 
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record the left ventricular monophasic action potential. A 
standard 6F bipolar electrode catheter with 10-mm interelec- 
trode spacing (USCI) was positioned in the right atrial append- 
age for atrial pacing. 
Recordings of monophasic action potentials. Monophasic 
action potentials from two to four sites on the right and left 
ventricular endocardium were recorded simultaneously in each 
patient by the contact electrode technique described previously 
(11,12,22-25). A total of 22 sites were recorded in eight 
patients with the long QT syndrome and 23 in eight control 
patients. Monophasic action potential signals (amplified and 
filtered at a frequency of 0.05 to 500 Hz), six surface lectro- 
cardiographic (ECG) leads and the radial artery pressure were 
displayed simultaneously on a 16-channel Mingograf strip 
chart recorder (Siemens-Elema) t a paper speed of 25 or 100 
mm/s. Monophasic action potentials were obtained during 
both sinus rhythm and constant atrial pacing (cycle length 
600 ms) after placement of the catheter electrode in a position 
providing continuous recordings with a stable amplitude, 
smooth configuration and isopotential diastolic baseline 
(phase 4) that persisted for at least 10 min. Once the contact 
catheter was stabilized, monophasic action potentials could be 
recorded continuously from the same endocardial site for long 
periods without additional catheter manipulation. 
Early afterdepolar~ations were defined as depolarizing af- 
terpotentials that interrupted or delayed repolarization of the 
action potential (11). The amplitude of early afterdepolariza- 
tions was defined as follows: When early afterdepolarizations 
showed reversal of depolarization, the amplitude was defined 
as the difference between the maximal diastolic potential 
during phase 4 and the maximal positive deflection of the early 
afterdepolarizations. When early afterdepolarizations did not 
show reversal of depolarization, the amplitude was defined as 
the difference between phase 4 and the first deviation of the 
smooth repolarization phase. The amplitude of early afterde- 
polarizations was expressed as a percent of the monophasic 
action potential amplitude (percent early afierdepolarization 
amplitude). The monophasic action potential duration was 
determined at 90% repolarization (90% monophask: action 
potential duration), which included early afterdepolarizations if 
present. The dispersion of 90% monophasic action potential 
duration was defined as the difference between the longest and 
shortest 90% monophasic action potential duration for each 
patient. The QT(U) interval was defined as the time between 
QRS onset and the point at which the line of maximal 
downslope of the T wave, or the late component of the T(U) 
complex, if present, crossed the baseline before the isoelectric 
UP interval (24,26). 
Protocol. Constant right atrial pacing at a cycle length of 
600 ms was performed with 2-ms rectangular stimuli at twice 
diastolic threshold elivered from a programmable stimulator 
(SEC-3102, Nihon Kohden). Monophasic action potentials 
were recorded before epinephrine infusion (control state) 
during constant atrial pacing for at least 3 rain until the 
monophasic action potential duration reached a new steady 
state (27). The mean 90% monophasic action potential dura- 
tion and QT(U) interval >3 consecutive beats during constant 
atrial pacing were used for analysis. 
Epinephrine infusion. Epinephrine was infused at a con- 
stant rate of 0.1 tzg/kg body weight per rain in both patient 
groups. After a steady state was achieved, the effect of epi- 
nephrine on ventricular arrhythmias was studied during sinus 
rhythm, and monophasic action potentials were recorded 
during constant atrial pacing (cycle length 600 ms), as de- 
scribed earlier (Protocol). 
Verapamil injection. Verapamil (0.1 mg/kg) was injected 
for 3 rain during continuous epinephrine infusion in both 
patient groups, and the effect of verapamil on ventricular 
arrhythmias induced by epinephrine was investigated. 
Monophasic action potentials were recorded uring constant 
atrial pacing (cycle length 600 ms) 5 min after verapamil 
injection, and the effect of verapamil on early afterdepolariza- 
tions and on monophasic action potential duration was inves- 
tigated. 
Propranolol injection. Propranolol (0.1 mg/kg) was also 
injected for 3 rain during continuous epinephrine infusion at 
~20 rain after verapamil injection to assess the effect on 
ventricular arrhythmias in both groups of patients. Monopha- 
sic action potentials were recorded during constant atrial 
pacing (cycle length 600 ms) 5 rain after propranolol injection, 
and the effect of propranolol on early afterdepolarizations a d 
on monophasic action potential duration was investigated. 
Statistical analysis. Data are reported as mean value -- 
SD. A repeated measures analysis of variance followed by the 
Scheff~ test was used to compare measurements made before 
and after serial drug administration. The Student test for 
unpaired data was used to compare differences between pa- 
tients with the long QT syndrome and control patients. A p 
~alue <0.(t5 was considered significant. 
Resul ts  
Sinus cycle length and systolic blood pressure. Epineph- 
rine significantly shortened the sinus cycle length in both 
patient groups (from 759 _+ 85 to 648 _+ 49 ms [p < 0.05] in 
patients with the long QT syndrome and from 858 -+ 105 to 
739 _+ 87 ms [p < 0.005] in control patients). Injection of 
verapamil during continuous epinephrine infusion did not 
change the sinus cycle length in either patient group (629 + 23 
and 730 ± 100 ms in patients with the long QT syndrome and 
control patients, respectively). Addition of propranolol during 
continuous epinephrine infusion significantly prolonged the 
sinus cycle length in both groups (848 + 137 and 946 _+ 80 ms 
[both p < 0.0005 vs. verapamil] in patients with the long QT 
syndrome and control patients, respectively). Epinephrine 
significantly increased systolic blood pressure during constant 
atrial pacing (cycle length 600 ms) in both groups (from 113 _+ 
12 to 139 : 18 mm Hg [p < 0.0005] in patients with the long 
QT syndrome and from 129 + 13 to 146 _+ 17 mm Hg [p < 
0.05] in control patients). Injection of verapamil during con- 
tinuous epinephrine infusion significantly decreased systolic 
blood pressure in both groups (119 _+ 19 and 125 _+ 15 mm Hg 
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Table 2. Electrophysiologic Data for Eight Patients With the Long QT Syndrome 
Control Epinephrine 
Recording %EAD Amp MAPD,~. Dispersion of QT Ventricular %EAD Amp MAPDgo Dispersion of QT Ventricular 
Site (%) (ms) MAPD,~ (ms) (ms) Arrhythmias (%) (ms) MAPDgo (ms) (ms) Arrhythmias 
Pt 1 
RV ant - -  330 ] 35 380 - -  +56% 360 } 70 450 - -  
RVOT - -  295 / - -  290 
Pt 2 
LV int" +~.~le':Jr 420 / +53% 485 ] 
RV ant - -  340 "~' 80 490 - -  - -  350 1 135 530 VPCs 
! 
RV sep - -  365 ) - -  350 
Pt 3 
LV R  arlt l t 3~7~} - -  315} 71 40 3~,0 - -  50 440 - -  
- -  " - -  365 
Pt 4 
LV Iat - -  28i) ! + 14% 400 1 
10 35O 75 520 VPCs ? 
RV sep - -  290 / - -  325 J 
Pt 5 
LV inf - -  ~,~,75 ] +64% 435 ] 
RV ant - -  360 I, - -  390 / 
RV scp - -  335 / 40 430 - -  - -  365 70 480 
RVOT - -  ]411 J - -  375 J 
Pt 6 
LV lat 325 ] - -  345 ] 
RV ant - -  335 ~ 20 380 - -  - -  365 ~ 20 440 - -  
/ J RV sep - -  315 J - -  345 
Pt 7 
LV lat - -  4111 ] - -  410 ] 
/ / 
RVOT 435 ~ 35 490 - -  - -  455 ~ 55 520 VPCs TdP 
/ / 
RV sep +53% 445 ) +78% 465 1 
Pt 8 
LV lat - -  375 • ] - -  400 1 
RVOT - -  345 ~ 30 430 - -  +56% 415 40 480 - -  
RV apex - -  355 J - -  375 J 
%EAD Amp = percent early afterdepolarization amplitude; LV inf = left ventricular inferior wall; LV lat = left ventricular lateral wall; MAPDgo = monophasic 
action potential duration at 90% repolarization: RV ant = right ventricu[ar anterior wall; RV sep = right ventricular septum; RVOT = fight ventricular outflow tract; 
VPCs = ventricular premature complexes: other abbreviations as in Table 1. 
[both p < 0.005 vs. epinephrine] in patients with the long QT 
syndrome and control patients, respectively). The addition of 
propranolol had no further effect on systolic blood pressure in 
either patient group (116 _+ 15 and 136 _+ 17 mm Hg in 
patients with the long QT syndrome and control patients, 
respectively). 
Early afterdepolarizations. Patients with long QT syndrome 
(Table 2). Before epinephrine infusion (control state), early 
afterdepolarizations were recorded in two of the eight patients 
with the long QT syndrome (2 of 22 recording sites) and were 
consistent with the late component of the T(U) wave. During 
constant atrial pacing (cycle length 600 ms), the mean percent 
early afterdepolarization amplitude was 38 _+ 22% (two sites) 
(Fig. 1A). Epinephrine increased the percent early afterdepo- 
larization amplitude to 66 - 18% (two sites) in association 
with an increase in the amplitude of the late component of the 
T(U) wave (Fig. 1B). Epinephrine also induced new early 
afterdepolarizations in another four patients with the long QT 
syndrome (four recording sites). Therefore, early afterdepo- 
larizations were recorded in six of eight patients with the long 
QT syndrome (6 of 22 recording sites) during epinephrine 
infusion (mean percent early afterdepolarization amplitude 
54 + 21%, (6 sites). Injection of verapamil during continuous 
epinephrine infusion eliminated early afterdepolarizations in
two of six patients with the long QT syndrome (two of six 
recording sites) and reduced the percent early afterdepolariza- 
tion amplitude slightly to 37 -+ 23% in the remaining four (four 
recording sites) (Fig. 1C). Addition of propranolol during 
continuous epinephrine infusion eliminated early afterdepolar- 
izations in two of the remaining four patients with the long QT 
syndrome (two of four recording sites) and reduced the 
percent early afterdepolarization amplitude to 24 -+ 3% in the 
other two (two recording sites) (Fig. 1D). 
Recordings of early afterdepolarizations were stable during 
the same protocol, and the shape and amplitude of early 
afterdepolarizations were constant during constant atrial pac- 
ing (constant RR interval) in patients with the long QT 
syndrome. Moreover, the amplitude of early afterdepolariza- 
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%EAD Amp 
(%) 
Verapamil During Epinephrine 
MAPD,~ o Dispersion of 
(ms) MAPD,~,I (ms) 
QT Ventricular 
(ms) Arrhythmias 
Propranolol During Epinephrine 
f'~EAD Amp MAPDgo Dispersion of QT Ventricular 
(%) (ms) MAPD~o (ms) (ms) Arrhythmias 
+45% 351) /
- -  29(I l 
- -  350 
- -  315 1 
- -  355 1 
+5% 365 
- -  325 J 
+58% 41(I] 
- -  38(I [ 
- -  345 / 
- -  35; J 
- -  345 / 
- -  365 / 
- -  345 / 
- -  370 ] 
- -  375 / 
- -  340 
- -  365 ] 
- -  345 / 
- -  355 J 
60 450 
70 500 
40 440 
40 500 VPCs 
65 460 
211 440 
35 390 
20 43(I 
+22C; 
+26q 
m 
335 ~ 50 390 - -  
285 J 
415 ] 
345 1 70 490 - -  
35O 
295 ~ 40 360 - -  
335 l 
275 ~ 25 360 - -  
300 1 
390 ) 
370 1 
335 [ 55 450 - -  
335 J 
330) 
335 / 20 390 - -  
315 / 
320) 
335 ~ 20 380 - -  
340 J 
365 ] 
345 ~ 20 420 - -  
355 J 
tions recorded in patients with the long QT syndrome was 
bradycardia dependent and increased after a long preceding 
RR interval after atrial pacing (Fig. 2). These characteristics of 
early afterdepolarizations were consistent with those of exper- 
imentally induced early afterdepolarizations. 
Control patients. In contrast, no early afterdepolarizations 
were recorded during the entire protocol in any control 
patient. 
Ventricular arrhythmias. No ventricular arrhythmias oc- 
curred during either sinus rhythm or constant atrial pacing in 
the control state in both patient groups (Fig. 3A). 
Patients with long QT syndrome. Epinephrine induced ven- 
tricular premature complexes in three of eight patients with the 
long QT syndrome (Fig. 3B). In one of these three patients, 
ventricular premature complexes originated from the peak of 
early afterdepolarizations that were augmented by epineph- 
rine, suggesting that these arrhythmias were closely related to 
the early afterdepolarizations (Fig. 3B). Moreover, in another 
of the three patients, epinephrine induced torsade de pointes 
(Fig. 4). Injection of verapamil during continuous epinephrine 
infusion abolished ventricular premature complexes in two of 
the three patients (Fig. 3C) and also suppressed subsequent 
torsade de pointes. Addition of propranolol during continuous 
epinephrine infusion abolished ventricular premature com- 
plexes in the remaining patient. 
Control patients. In contrast, no ventricular arrhythmias 
were induced during the entire protocol in any control patient. 
Ninety-percent monophasic action potential duration. The 
mean 90% monophasic action potential duration was signifi- 
cantly longer in patients with the long QT syndrome (22 sites) 
than in control patients (23 sites) during constant atrial pacing 
(cycle length 600 ms) in the control state (348 __ 48 vs. 246 _+ 
14 ms, p < 0.0005) (Fig. 5). 
Patients with the long QT syndrome. In patients with the 
long QT syndrome, epinephrine prolonged the 90% monopha- 
sic action potential duration markedly to 381 _+ 49 ms (p < 
0.0005 vs. control state), whereas injection of verapamil during 
continuous epinephrine infusion shortened it to 355 _+ 28 ms 
(p < 0.01 vs. epinephrine). Addition of propranolol during 
continuous epinephrine infusion slightly shortened it further to 
337 _+ 32 ms (p = 0.09 vs. verapamil) (Fig. 1 and 5A). 
Control patients. In contrast, epinephrine prolonged the 
9(1% monophasic action potential duration slightly to 250 _+ 
14 ms (p < 0.05 vs. control state) in the control patients; 
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F i g u r e  l. Recordings of monophasic achon potentials during constant 
atrial pacing (cycle length 600 ms) before epinephrine infusion (A); 
during epinephrine infusion (0.1 tzg/kg per rain) (B); after verapamil 
injection (0.1 togA:g) during epinephrine infusion (C); and after 
propranolol injection (0.1 mg/kg) during epinephrine infusion (D) in 
Patient 2 with the long QT syndrome. Simultaneous recordings of 
electrocardiographic lead V 3 and the monophasic action potentials 
from the left ventricular inferior wall (LVinf MAP) are shown. In the 
control state, early afterdepolarizations were recorded (arrows) and 
were consistent with the late components ofthe T(U) wave in lead V3 
(A). The amplitude of the early afterdepolarizations (%EADamp) was 
22%, and the 90% monophasic a tion potential duration was 420 ms. 
Epinephrine increased the amplitude of early afterdepolarizations to 
53% in association with an increased amplitude of the late component 
of the T(U) wave and prolonged the 90% monophasic a tion potential 
duration to 485 ms (B). Verapamil injection during epinephrine 
infusion reduced the amplitude of early afterdepolarizations to 38% 
and shortened the 90% monophasic action potential duration to 
420 ms (C). Addition of propranolol during epinephrine infusion 
further reduced the amplitude of early afterdepolarizations to 26% 
and further shortened the 90% monophasie action potential duration 
to 415 ms (D). 
however, no change occurred after injection of verapamil and 
additional propranolol during continuous epinephrine infusion 
(verapamil 252 ± 13 ms, propranolol 251 + 13 ms) (Fig. 5B). 
Dispers ion of 90% monophasic  action potential duration. 
The mean dispersion of 90% monophasic action potential 
duration was significantly larger in the eight patients with the 
long QT syndrome than in the eight control patients during 
constant atrial pacing (cycle length 600 ms) in the control state 
(36 ± 20 vs. 18 ± 6 ms, p < 0.05) (Fig. 6). 
Patients with long QT syndrome. In patients with the long 
QT syndrome, epinephrine increased the dispersion to 64 ± 
34 ms (p < 0.005 vs. control state), whereas injection of 
verapamil during continuous epinephrine infusion decreased it 
to 44 _+ 19 ms (p < 0.05 vs. epinephrine). Addition of 
propranolol during continuous epinephrine infusion did not 
change dispersion (38 _+ 19 ms) (Fig. 6A). 
Control patients. In contrast, dispersion of 90% monopha- 
sic action potential duration did not change during the entire 
protocol in the control patients (epinephrine 21 +_ 7 ms, 
verapamil 20 _+ 9 ms, propranolol 18 _+ 9 ms) (Fig. 6B). 
QT interval. The mean QT interval was significantly onger 
in the eight patients with the long QT syndrome than in the 
eight control patients during constant atrial pacing (cycle 
length 600 ms) in the control state (413 _+ 57 vs. 318 _ 9 ms, 
p < 0.0005). 
Patients with long QT syndrome. In patients with the long 
QT syndrome, epinephrine prolonged the QT interval mark- 
edly to 483 ___ 37 ms (p < 0.01 vs. control state). Injection of 
verapamil during continuous epinephrine infusion shortened 
the QT interval to 451 ± 36 ms; but this difference was not 
statistically significant. Addition of propranolol during contin- 
uous epinephrine infusion further shortened it to 405 _+ 46 ms. 
Although the difference between verapamil and propranolol 
was also not statistically significant, the difference between 
epinephrine and propranolol was significant (p < 0.005). 
Control subjects. In contrast, epinephrine prolonged the 
QT interval slightly to 326 _+ 5 ms (p < 0.05 vs. control state) 
in control patients. Injection of verapamil and additional 
propranolol during continuous epinephrine infusion did not 
change the QT interval (verapamil 328 __- 8 ms, propranolol 
327 _+ 7 ms). 
Discuss ion  
There were two major findings of the present study: 1) 
Epinephrine induced or augmented early afterdepolarizations, 
induced ventricular arrhythmias, prolonged markedly the 90% 
monophasic action potential duration and the QT interval and 
increased the dispersion of 90% monophasic action potential 
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duration in patients with congenital long QT syndrome. 2) 
Both verapamil and propranolol were effective in suppressing 
early afterdepolarizations a d epinephrine-induced v ntricular 
arrhythmias, in shortening the 90% monophasic action poten- 
tial duration and the QT interval and in decreasing the 
dispersion of 90% monophasic action potential duration. 
Role of cateeholamines in early afterdepolarizations and 
ventricular arrhythmias in congenital long QT syndrome. 
Physical exertion and strong emotion are known to precipitate 
syncope and sudden death in patients with congenital long QT 
syndrome (28). In addition, exercise stress testing (29-31) or 
isoproterenol infusion (31,32) are reported to produce para- 
doxic prolongation of the QT interval and to occasionally 
precipitate torsade de pointes. Thus, sympathetic stimulation 
or catecholamines play an important role in the exaggeration 
of repolarization abnormalities in this syndrome. 
Since Yanowitz et al. (33) demonstrated that left stellate 
ganglion stimulation and right stellate ganglion interruption 
prolonged the QT interval in dogs, the "sympathetic mbal- 
ance" hypothesis for congenital long QT syndrome has been 
proposed (28). However, experimental models based on in- 
tense stimulation of the left stellate ganglion and total inter- 
ruption of the right ganglion do not produce QT prolongation 
and torsade de pointes as severe as those found in the clinical 
setting. Moreover, Caikins et al. (34) recently used positron 
emission tomography with carbon-ll hydroxyephedrine 
(HED) to demonstrate hat patients with congenital long QT 
syndrome have a normal distribution and density of sympa- 
thetic nerve terminals. 
Recently, several experimental models of long QT syn- 
drome (1-7) and clinical studies using monophasic action 
potentials (8-12,16) have suggested that early afterdepolariza- 
tions and triggered activity, were important in the genesis of QT 
prolongation and torsade de pointes in congenital long QT 
Figure 2. Simultaneous recordings ofelectrocardiographic leads V1, 
V 3 and V 5 and the monophasic action potentials from the right 
ventricular anterior wall (RVant MAP), right ventricular septum 
(RVsep MAP) and left ventricular inferior wall (LVinf MAP) during 
epinephrine infusion (0.1/~g/kg per min) in Patient 2 with the long QT 
syndrome. Tracings how the last two beats of right atrial pacing 
(pacing cycle length [PCL] 600 ms) and the subsequent two sinus beats. 
Early afterdepolarizations were recorded in the left ventricular 
monophasic a tion potentials (arrows) and were consistent with the 
late components of the T(U) wave in lead V 3 (arrows). The amplitude 
of early afterdepolarizations (%EADamp) was 53% and the 90% 
monophasic a tion potential duration was 485 ms during atrial pacing. 
Note that the amplitude of early afterdepolarizations increased to 
59%, and the 90% monophasic a tion potential duration was pro- 
longed to 510 ms, after a long preceding RR interval (860 ms) after 
atrial pacing. S = atrial pacing stimulus. 
syndrome. Ben-David and Zipes (24) have demonstrated that 
ansae subclaviae stimulation or norepinephrine caused an 
increase in cesium-induced arly afterdepolarizations and tor- 
sade de pointes in dogs. Shimizu et al. (11), using monophasic 
action potentials, found that isoproterenol induced early after- 
depolarizations in four of six patients with congenital long QT 
syndrome. 
In the present study, epinephrine induced or augmented 
early afterdepolarizations i  ix of eight patients with the long 
QT syndrome and significantly prolonged the 90% monophasic 
action potential duration and QT interval. Epinephrine also 
induced ventricular premature complexes in three of eight 
patients and torsade de pointes in one of these three. More- 
over, the ventricular premature complexes were demonstrated 
to originate from the peak of the early afterdepolarizations, 
which were augmented by epinephrine in one of these three 
patients• By contrast, none of the early afterdepolarizations, 
ventricular arrhythmias or marked prolongation of the 90% 
monophasic action potential duration and QT interval were 
1306 SHIMIZU ET AL. JACC Vol. 26, No. 5 
VERAPAMIL AND PROPRANOLOL IN LONG QT SYNDROME November 1, 1995:1299 309 
A. Control 
~' =-L~ . . . . .  : . . . . . . . . . . .  L .  ! i I t 
_= L I _  i , . ! . . I LL  .i L ! "  ~ ~ , ': 
MAP ,_.f 
B. Epinephrine 
:i1 
I~ . ~/\t/~' l 'L '(,./''' j" L ,"  ~"h.v 
I i" i i i " J i  
M/~t  . . . .  ' ', . . . . . . .  
: \ : ~ '~ " , i , ', ! '~ i ' \ , \ , !  
1see 
C. Ver~g~amil + Epinephrine 
,~ , I " : :~  , ' :  ' ' ' 
CEi"5 i2 ) - ] : -  -L  ' i 
Figure 3. Recordings ofventricular p emature complexes 
induced by epinephrine infusion (0.1/~g/kg per min) and 
the effect of verapamil injection (0.1 mg/kg) during epi- 
nephrine infusion on ventricular premature complexes in 
Patient 2 with the long QT syndrome. All tracings are 
from electrocardiographic lead V3 and the monophasic 
action potential recordings from the left ventricular infe- 
rior (LVinf MAP) and right ventricular anterior walls 
(RVant MAP) during sinus rhythm. In the control state 
(A) there was no ventricular arrhythmia, lthough early 
afterdepolarizations were recorded in the left ventricular 
inferior wall monophasic a tion potentials (arrows) (A). 
Epinephrine increased the amplitude of early afterdepo- 
larizations (arrows) and induced ventricular premature 
complexes that arose from the peak (asterisk) of the early 
afterdepolarizations, suggesting that the ventricular pre- 
mature complexes were closely related to the early after- 
depolarizations (B). Verapamil injection during epineph- 
rine infusion abolished all ventricular premature 
complexes, although early afterdepolarizations were still 
present (arrows) (C). 
induced by epinephrine in any control patient. These results 
suggest that catecholamines play a significant role in the 
generation of early afterdepolarizations and repolarization 
abnormalities and that early afterdepolarizations are closely 
linked to the initiating beats at least (ventricular premature 
complexes) of torsade de pointes in congenital ong QT 
syndrome. However, the dispersion of 90% monophasic action 
potential duration was also increased by epinephrine in the 
patients with the long QT syndrome. Therefore, the possibility 
that torsade de pointes is perpetuated by a reentrant mecha- 
nism initiated by increased ispersion of repolarization cannot 
be excluded (35,36). 
Cellular mechanism of early afterdepolarizations and ef- 
fects of verapamil and propranolol in congenital long QT 
syndrome. There are several cellular mechanisms that are 
postulated to be critical in the generation of early afterdcpo- 
larizations in the long QT syndrome. These mechanisms 
include the sodium ion "window" or slowly inactivating cur- 
rent, potassium ion currents, calcium ion "window" current 
and the sodium/calcium exchange mechanism. Keating et al. 
(37) recently reported that the congenital long QT syndrome 
phenotype was tightly linked to the Harvey ras-1 gene on 
chromosome 11 in a large family. The Harvey ras-1 gene has 
been identified (38) and shown to have G protein functions, 
including signal transmitters in potassium ion channels. There- 
fore, Keating et al. (37,38) hypothesized that mutation of this 
gene in congenital long QT syndrome alters G protein function 
and impairs the delayed rectifier potassium ion current, caus- 
ing prolongation of the action potential and QT interval (39). 
However, January and co-workers (5,6), using voltage- 
clamped Purkinje fibers, suggested that the time- and voltage- 
dependent L-type calcium ion current within its "window" was 
important in the genesis of early afterdepolarizations after 
lengthening of the action potential plateau (conditioning 
phase). These investigators also demonstrated that calcium ion 
channel blockers (e.g., verapamil) directly suppressed the 
L-type calcium ion current and abolished early afterdepolar- 
izations. Moreover, catecholamines are reported to enhance 
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Figure 4. Torsade de pointes induced by epinephrine 
infusion (0.1/,g/kg per rain) in Patient 7 with the long 
QT syndrome. Tracings are continuous recordings 
from electrocardiographic lead V 3 and the monophasic 
action potentials from the right ventricular septum 
(RVsep MAP) during sinus rhythm. Early afterdepo- 
larizations were seen in the right ventricular monopha- 
sic action potentials (arrows), and torsade de pointes 
was subsequently induced (asterisk). Even after termi- 
nation of torsade de pointes, the monophasic action 
potential recording was stable, and early afterdepolar- 
izations were still present (arrows), 
Epinephrine (0.1 pg/kgJmin) 
continuous 
V3 ~~I 
continuous 
RVsop 
V3 
RVImp 
I 5  mV 
i I 
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the L-type calcium ion "window" current or calcium ion release 
from the sarcoplasmic reticulum and were shown to enhance 
early afterdepolarizations in several experimental studies 
(24,40). Therefore, propranolol (a beta-blocker) may suppress 
early afterdepolarizations as a result of interference with these 
pathways. 
In the present study, both verapamil and propranolol 
abolished or suppressed both early afterdepolarizations and 
epinephrine-induced ventricular arrhythmias and also im- 
proved repolarization variables. In contrast, neither verapamil 
nor proranolol affected repolarization variables in any control 
patient. These findings are consistent with the results of 
experimental studies (5,6). 
According to the results of the present study, patients with 
congenital long QT syndrome may have a primary myocardial 
abnormality (prolonged action potential duration) controlled 
by the sum of several membrane currents (e.g., congenital 
impairment of the potassium ion current), and catecholamines 
may induce early afterdepolarizations a d ventricular arrhyth- 
mias as a result of an enhanced L-type calcium ion "window" 
current, so that both verapamil and propranolol effectively sup- 
press early afterdepolarizations a d ventricular arrhythmias. 
Figure 5. Plots of changes in the 90c~'~ , 
monophasic action potential duration 5oo 
(MAPD9o) during constant atrial pacing 
(cycle length 600 ms) beibre epinephrine 
infusion (Control); during epinephrine infu- 
sion (0.1 pg/kg per rain); after verapamil 
injection (0.1 mg/kg) during epinephrine 
infusion; and after propranolol injection 3oo 
(0.l mg/kg) during epinephrine infusion in 
patients with congenital long QT syndrome 
(LQTS) (22 recording sites) (A) and control 
patients (23 recording sites) (B). 
A LQTS patients (n=22) 
MAPDgo 
(msec) p<0.0005 p<0.01 p=0.09 
B Control patients (n=23) 
MAPDgO 
(msec) 
p<O.05 p=n.s,  p=n.s. 
5OO 
4OO 
300 
2OO 20O 
348¢48 381 -+49 355±28 337±32 
T T 
Control Epinephrine Verapamil Proprano~ol 
+ Epinephrine + Epinephrine 
f 
246=14 250±14 252-+13 251-+13 
Control Epinephrine Verapamil Propranolol 
+ Epinephrine + Epinephrine 
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Figure 6. Plots of changes in the dispersion 
of 90% monophasic action potential dura- 
tion (Dispersion of MAPD9o ) during con- 
stant atrial pacing (cycle length 600 ms) 
before epinephrine infusion (Control); dur- 
ing epinephrine infusion (0.1 /zg/kg per 
min); after verapamil njection (0.1 mg/kg) 
during epinephrine infusion; and after pro- 
pranolol injection (0.1 mg/kg) during epi- 
nephrine infusion in eight patients with the 
congenital long QT syndrome (LQTS) (A) 
and eight control patients (B). 
Limitations of the study. There are several limitations to 
the present study. 
1. We cannot completely exclude the possibility that the 
"humps" we called early afterdepolarizations were recording 
artifacts. However, we assumed that they were not artifacts for 
the following reasons: a) all monophasic action potential 
recordings had a stable amplitude and configuration; b) 
changes in the early afterdepolarization amplitude were closely 
correlated with changes in the late component of the T(U) 
waves in patients with the long QT syndrome; c) the amplitude 
of early afterdepolarizations recorded in patients with the long 
QT syndrome was bradycardia dependent, and this character- 
istic is similar to that of experimentally induced early afterde- 
polarizations; and d) no early afterdepolarizations were re- 
corded in any control patient. 
2. Monophasic action potential recordings are reported to 
reflect the potential from both ventricular cells and Purkinje 
fibers. Sicouri and Antzelevitch (4l) recently described the 
existence of M cells that exhibit electrophysiologic character- 
istics intermediate between those of ventricular cells and 
Purkinje fibers and have a markedly prolonged action potential 
duration in the canine ventricle. Therefore, it is possible that 
the monophasic action potential recordings may reflect the 
potential from such M cells with a prolonged action potential 
duration. 
3. The monophasic action potential recordings were ob- 
tained simultaneously from only two to four sites in each 
patient. This small number of recording sites limits the calcu- 
lation of dispersion of action potential duration across the 
entire ventricle, and more detailed monophasic action poten- 
tial recordings are necessary to obtain a more precise disper- 
sion value. 
4. Although the effects of verapamil and additional pro- 
pranolol were investigated uring continuous epinephrine 
infusion, there were differences between responses with regard 
to sinus cycle length and systolic blood pressure to these drugs. 
Verapamil did not change the sinus cycle length despite its 
negative chronotropism. This finding may be due to the 
injection of verapamil during epinephrine infusion and also 
reflective of beta-adrenergic stimulation to the decreased 
systolic blood pressure. Additional propranolol prolonged the 
sinus cycle length as a result of its negative chronotropism and 
blocking of the circulating epinephrine. However, verapamil 
decreased systolic blood pressure as a result of its negatively 
inotropic effect. Additional propranolol during epinephrine 
infusion did not affect systolic blood pressure, probably be- 
cause of residual alpha-adrenergic stimulation. 
5. We could not evaluate the effect of propranolol alone but 
only the additive ffect of propranolol to that of verapamil on 
early afterdepolarizations, ventricular arrhythmias and 
monophasic action potential duration. However, propranolol 
further improved repolarization abnormalities compared with 
verapamil alone. Therefore, we considered propranolol to be 
effective. 
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